MEN1 and pachyonychia congenita: Although candidates like leflunomide, an inhibitor of dihydroorotate dehydrogenase, have been suggested as potential treatments for MEN1 mutation-positive tumors (17), no established chemotherapeutic regimen has proven effective for sporadic PC harboring MEN1 mutations.